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• Most cigarette flavorings, such as grape and strawberry, 
were prohibited by the Family Smoking Prevention and 
Tobacco Control Act of 2009 (U.S. House), however, 
menthol remains an unregulated cigarette additive. 
• Menthol has a unique cooling effect, which may cause 
smokers to inhale the smoke more deeply without feeling 
respiratory discomfort (TPSAC 2011). 
• Menthol cigarette smoking is most prevalent among 
African Americans, youth ages 12-17, women of any age, 
and people who have recently started smoking (NSDUH 
2009). 
• In terms of quit attempts, studies have widely shown 
reduced success in smoking cessation in menthol cigarette 
smokers as compared to non-menthol cigarette smokers 
(Ghandi et al. 2009; Okuyemi et al. 2007). 
• While menthol smokers have a more difficult time quitting 
smoking, the specific mechanism for this observation is 
unknown, though more severe withdrawal symptoms have 
previously shown to lead to reduced success in quit 
attempts. 
• Therefore, we aim to examine the differences in 
withdrawal symptomatology in menthol versus non-
menthol cigarette smokers during short-term smoking 
abstinence. 
• It is hypothesized that menthol cigarette smokers will 
have more severe withdrawal symptoms than the non-
menthol smokers during the short-term abstinence. 
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This is a secondary data analysis from a study titled “Menstrual 
Phase and Depressive Symptoms in Acute Smoking 
Abstinence” (PI: S. Allen), which aimed to determine the effect 
of depressive symptoms and ovarian hormones on withdrawal 
symptoms, nicotine craving, smoking urges, premenstrual 
symptoms, and cortisol levels during short-term smoking 
abstinence.  
 
Eligibility Criteria 
• Healthy women ages 18-40 with regular menstrual cycles 
• ≥ 5 cigarettes/day for  ≥ 1 year 
• No exogenous hormones or psychotropic medications 
• No recent or planned pregnancy or breastfeeding 
Protocol 
• Participants participated in a six-day testing week with two 
days of ad libitum smoking followed by four days of 
biochemically verified smoking abstinence, with 
symptomatology measures taken each day. 
• Menthol status was determined on the first day 
Statistical Analysis 
• Descriptive statistics 
• Linear regression models comparing each day of smoking 
abstinence to the baseline (ad libitum, day 2) 
 
Table 1. Smoking-Related Symptomatology Measures 
*Because menthol and non-menthol smokers were significantly different in age, race, and education levels, these variables were 
controlled for in the analyses. 
  
• Contrary to our hypothesis, non-menthol cigarette smokers 
showed more severe withdrawal symptoms during the short-term 
smoking abstinence. 
• Further, menthol cigarette smokers showed higher withdrawal 
symptoms during ad libitum smoking. 
• These data suggest that non-menthol smokers experience greater 
withdrawal during abstinence whereas menthol smokers 
experience greater withdrawal on an everyday basis. 
Introduction Results 
All (n=221) 
Menthol  
(n=110) 
Non-Menthol 
(n=111) 
p-value 
Demographics 
Age* 28.9 ± 6.6 30.0 ± 6.6 27.7 ± 6.5 0.010 
Race (% White)* 59.1% 40.9% 77.3% <0.001 
Education (% < Some College)* 32.9% 43.5% 22.5% 0.004 
Smoking-Related 
Cigarettes/Day 12.6 ± 5.7 11.9 ± 5.5 13.3 ± 5.8 0.064 
Time to First Cigarette (minutes) 41.0 ± 52.0 38.3 ± 58.6  43.7 ± 44.7 0.450 
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Figure 2. Absolute Values (Adjusted Mean ± Standard Error) of Withdrawal Symptoms by Menthol Status 
Highlights 
 
• Menthol smokers showed greater 
“withdrawal” and “anticipated relief 
from negative affect” during ad 
libitum smoking (p=0.027, p=0.079). 
• Non-menthol smokers showed greater 
“desire to smoke” on the third day of 
smoking abstinence (p=0.031). 
• Non-menthol smokers also showed a 
greater increase in “desire to smoke” 
and “anticipated relief from negative 
affect” from ad libitum smoking to 
the 3rd day of smoking abstinence 
(p=0.011, p=0.047). 
 
* 
* 
* 
Questionnaire Reference Subscales Range 
Minnesota 
Withdrawal Scale 
(MNWS) 
Hughes & 
Hatsukami 
1986 
Craving 0-4 
Withdrawal 0-28 
Questionnaire on 
Smoking Urges 
(QSU – Brief) 
Tiffany & 
Drobes 
1991 
Desire to Smoke 5-35 
Anticipated Relief from Negative 
Affect 
5-35 
Table 2. Demographics and Smoking Behavior (n=221) 
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• This analysis does not help to explain why menthol smokers have higher 
relapse rates than menthol smokers. 
• This study included a large, diverse sample and was the first to examine 
differences in withdrawal symptoms between menthol and non-menthol 
smokers. 
• However, this was a secondary data analysis project. An even larger study 
including both men and women should aim to primarily examine the 
differences between menthol and non-menthol cigarette smokers’ 
withdrawal symptoms during an actual smoking cessation to determine 
whether more severe withdrawal symptoms affect relapse rates. 
Figure 1. Data Collection Procedures 
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